866-997-4948(US-Canada Toll Free)

Pharmaceuticals Global Industry Almanac 2017

Published By :

MarketLine

Published Date : May 2017

Category :

Pharmaceutical

No. of Pages : 505 Pages

Pharmaceuticals Global Industry Almanac 2017

Summary

Global Pharmaceuticals industry profile provides top-line qualitative and quantitative summary information including: market share, market size (value 2012-16, and forecast to 2021). The profile also contains descriptions of the leading players including key financial metrics and analysis of competitive pressures within the market.

Synopsis

Essential resource for top-line data and analysis covering the global pharmaceuticals market. Includes market size data, textual and graphical analysis of market growth trends and leading companies.

Key Highlights

- The pharmaceuticals market consists of ethical drugs only and does not include consumer healthcare or animal healthcare. Market values have been calculated at ex-factory prices (the value at which manufacturers sell the drugs to distributors). Any currency conversions used in the production of this report have been calculated at constant 2016 annual average exchange rates.
- The global pharmaceuticals market had total revenues of $946.1bn in 2016, representing a compound annual growth rate (CAGR) of 6.1% between 2012 and 2016.
- The US, Japan and China are the largest global pharmaceutical markets followed by the four biggest European markets: France, Germany, the UK, and Italy. Amongst that number it is China that is producing the strongest growth every year, whilst the European states have been stifled due to current healthcare spending cultures in the region.
- The patent cliff has caused revenue losses for many companies. The sales of Pfizer, Novartis and Merck & Co. fell when they lost their patents for Lipitor, Diovan and Singulair, respectively. AstraZeneca has been particularly affected by the patent cliff.

Scope

- Save time carrying out entry-level research by identifying the size, growth, and leading players in the global pharmaceuticals market
- Use the Five Forces analysis to determine the competitive intensity and therefore attractiveness of the global pharmaceuticals market
- Leading company profiles reveal details of key pharmaceuticals market players global operations and financial performance
- Add weight to presentations and pitches by understanding the future growth prospects of the global pharmaceuticals market with five year forecasts

Reasons to buy

- What was the size of the global pharmaceuticals market by value in 2016?
- What will be the size of the global pharmaceuticals market in 2021?
- What factors are affecting the strength of competition in the global pharmaceuticals market?
- How has the market performed over the last five years?
- Who are the top competitors in the global pharmaceuticals market?
Table of Contents
EXECUTIVE SUMMARY
Market value
Market value forecast
Geography segmentation
Market share
Introduction
What is this report about?
Who is the target reader?
How to use this report
Definitions
Global Pharmaceuticals
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Asia-Pacific
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Europe
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in France
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Germany
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Australia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Brazil
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Canada
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in China
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in India
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Indonesia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Italy
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Japan
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Mexico
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The Netherlands
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in North America
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Russia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Scandinavia
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Pharmaceuticals in Singapore
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Africa
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in South Korea
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Spain
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in Turkey
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United Kingdom
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Pharmaceuticals in The United States
Market Overview
Market Data
Market Segmentation
Market outlook
Five forces analysis
Macroeconomic indicators
Company Profiles
Leading companies
Appendix
Methodology
About MarketLine

List of Tables
Table 1: Global pharmaceuticals market value: $ billion, 201216
Table 2: Global pharmaceuticals market geography segmentation: $ billion, 2016
Table 3: Global pharmaceuticals market share: % share, by value, 2016
Table 4: Global pharmaceuticals market value forecast: $ billion, 201621
Table 5: Asia-Pacific pharmaceuticals market value: $ billion, 201216
Table 6: AsiaPacific pharmaceuticals market geography segmentation: $ billion, 2016
Table 7: Asia-Pacific pharmaceuticals market share: % share, by value, 2016
Table 8: Asia-Pacific pharmaceuticals market value forecast: $ billion, 201621
Table 9: Europe pharmaceuticals market value: $ billion, 201216
Table 10: Europe pharmaceuticals market geography segmentation: $ billion, 2016
Table 11: Europe pharmaceuticals market share: % share, by value, 2016
Table 12: Europe pharmaceuticals market value forecast: $ billion, 201621
Table 13: France pharmaceuticals market value: $ billion, 201216
Table 14: France pharmaceuticals market geography segmentation: $ billion, 2016
Table 15: France pharmaceuticals market share: % share, by value, 2016
Table 16: France pharmaceuticals market value forecast: $ billion, 201621
Table 17: France size of population (million), 201216
Table 18: France gdp (constant 2005 prices, $ billion), 201216
Table 19: France gdp (current prices, $ billion), 201216
Table 20: France inflation, 201216
Table 21: France consumer price index (absolute), 201216
Table 22: France exchange rate, 201216
Table 23: Germany pharmaceuticals market value: $ billion, 201216
Table 24: Germany pharmaceuticals market geography segmentation: $ billion, 2016
Table 25: Germany pharmaceuticals market share: % share, by value, 2016
Table 26: Germany pharmaceuticals market value forecast: $ billion, 201621
Table 27: Germany size of population (million), 201216
Table 28: Germany gdp (constant 2005 prices, $ billion), 201216
Table 29: Germany gdp (current prices, $ billion), 201216
Table 30: Germany inflation, 201216
Table 31: Germany consumer price index (absolute), 201216
Table 32: Germany exchange rate, 201216
Table 33: Australia pharmaceuticals market value: $ billion, 201216
Table 34: Australia pharmaceuticals market geography segmentation: $ billion, 2016
Table 35: Australia pharmaceuticals market share: % share, by value, 2016
Table 36: Australia pharmaceuticals market value forecast: $ billion, 201621
Table 37: Australia size of population (million), 201216
Table 38: Australia gdp (constant 2005 prices, $ billion), 201216
Table 39: Australia gdp (current prices, $ billion), 201216
Table 40: Australia inflation, 201216
Table 41: Australia consumer price index (absolute), 201216
Table 42: Australia exchange rate, 201216
Table 43: Brazil pharmaceuticals market value: $ billion, 201216
Table 44: Brazil pharmaceuticals market geography segmentation: $ billion, 2016
Table 45: Brazil pharmaceuticals market share: % share, by value, 2016
Table 46: Brazil pharmaceuticals market value forecast: $ billion, 201621
Table 47: Brazil size of population (million), 201216
Table 48: Brazil gdp (constant 2005 prices, $ billion), 201216
Table 49: Brazil gdp (current prices, $ billion), 201216
Table 50: Brazil inflation, 201216
Table 51: Brazil consumer price index (absolute), 201216
Table 52: Brazil exchange rate, 201216
Table 53: Canada pharmaceuticals market value: $ billion, 201216
Table 54: Canada pharmaceuticals market geography segmentation: $ billion, 2016
Table 55: Canada pharmaceuticals market share: % share, by value, 2016
Table 56: Canada pharmaceuticals market value forecast: $ billion, 201621
Table 57: Canada size of population (million), 201216
Table 58: Canada gdp (constant 2005 prices, $ billion), 201216
Table 59: Canada gdp (current prices, $ billion), 201216
Table 60: Canada inflation, 201216
Table 61: Canada consumer price index (absolute), 201216
Table 62: Canada exchange rate, 201216
Table 63: China pharmaceuticals market value: $ billion, 201216
Table 64: China pharmaceuticals market geography segmentation: $ billion, 2016
Table 65: China pharmaceuticals market share: % share, by value, 2016
Table 66: China pharmaceuticals market value forecast: $ billion, 201621
Table 67: China size of population (million), 201216
Table 68: China gdp (constant 2005 prices, $ billion), 201216
Table 69: China gdp (current prices, $ billion), 201216
Table 70: China inflation, 201216
Table 71: China consumer price index (absolute), 201216
Table 72: China exchange rate, 201216
Table 73: India pharmaceuticals market value: $ billion, 201216
Table 74: India pharmaceuticals market geography segmentation: $ billion, 2016
Table 75: India pharmaceuticals market share: % share, by value, 2016
Table 76: India pharmaceuticals market value forecast: $ billion, 201621
Table 77: India size of population (million), 201216
Table 78: India gdp (constant 2005 prices, $ billion), 201216
Table 79: India gdp (current prices, $ billion), 201216
Table 80: India inflation, 201216
Table 81: India consumer price index (absolute), 201216
Table 82: India exchange rate, 201216
Table 83: Indonesia pharmaceuticals market value: $ billion, 201216
Table 84: Indonesia pharmaceuticals market geography segmentation: $ billion, 2016
Table 85: Indonesia pharmaceuticals market share: % share, by value, 2016
Table 86: Indonesia pharmaceuticals market value forecast: $ billion, 201621
Table 87: Indonesia size of population (million), 201216
Table 88: Indonesia gdp (constant 2005 prices, $ billion), 201216
Table 89: Indonesia gdp (current prices, $ billion), 201216
Table 90: Indonesia inflation, 201216
Table 91: Indonesia consumer price index (absolute), 201216
Table 92: Indonesia exchange rate, 201216
Table 93: Italy pharmaceuticals market value: $ billion, 201216
Table 94: Italy pharmaceuticals market geography segmentation: $ billion, 2016
Table 95: Italy pharmaceuticals market share: % share, by value, 2016
Table 96: Italy pharmaceuticals market value forecast: $ billion, 201621
Table 97: Italy size of population (million), 201216
Table 98: Italy gdp (constant 2005 prices, $ billion), 201216
Table 99: Italy gdp (current prices, $ billion), 201216
Table 100: Italy inflation, 201216
Table 101: Italy consumer price index (absolute), 201216
Table 102: Italy exchange rate, 201216
Table 103: Japan pharmaceuticals market value: $ billion, 201216
Table 104: Japan pharmaceuticals market geography segmentation: $ billion, 2016
Table 105: Japan pharmaceuticals market share: % share, by value, 2016
Table 106: Japan pharmaceuticals market value forecast: $ billion, 201621
Table 107: Japan size of population (million), 201216
Table 108: Japan gdp (constant 2005 prices, $ billion), 201216
Table 109: Japan gdp (current prices, $ billion), 201216
Table 110: Japan inflation, 201216
Table 111: Japan consumer price index (absolute), 201216
Table 112: Japan exchange rate, 201216
Table 113: Mexico pharmaceuticals market value: $ billion, 201216
Table 114: Mexico pharmaceuticals market geography segmentation: $ billion, 2016
Table 115: Mexico pharmaceuticals market share: % share, by value, 2016
Table 116: Mexico pharmaceuticals market value forecast: $ billion, 201621
Table 117: Mexico size of population (million), 201216
Table 118: Mexico gdp (constant 2005 prices, $ billion), 201216
Table 119: Mexico gdp (current prices, $ billion), 201216
Table 120: Mexico inflation, 201216
Table 121: Mexico consumer price index (absolute), 201216
Table 122: Mexico exchange rate, 201216
Table 123: Netherlands pharmaceuticals market value: $ billion, 201216
Table 124: Netherlands pharmaceuticals market geography segmentation: $ billion, 2016
Table 125: Netherlands pharmaceuticals market share: % share, by value, 2016
Table 126: Netherlands pharmaceuticals market value forecast: $ billion, 201621
Table 127: Netherlands size of population (million), 201216
Table 128: Netherlands gdp (constant 2005 prices, $ billion), 201216
Table 129: Netherlands gdp (current prices, $ billion), 201216
Table 130: Netherlands inflation, 201216
Table 131: Netherlands consumer price index (absolute), 201216
Table 132: Netherlands exchange rate, 201216
Table 133: North America pharmaceuticals market value: $ billion, 201216
Table 134: North America pharmaceuticals market geography segmentation: $ billion, 2016
Table 135: North America pharmaceuticals market share: % share, by value, 2016
Table 136: North America pharmaceuticals market value forecast: $ billion, 201621
Table 137: Russia pharmaceuticals market value: $ billion, 201216
Table 138: Russia pharmaceuticals market geography segmentation: $ billion, 2016
Table 139: Russia pharmaceuticals market share: % share, by value, 2016
Table 140: Russia pharmaceuticals market value forecast: $ billion, 201621
Table 141: Russia size of population (million), 201216
Table 142: Russia gdp (constant 2005 prices, $ billion), 201216
Table 143: Russia gdp (current prices, $ billion), 201216
Table 144: Russia inflation, 201216
Table 145: Russia consumer price index (absolute), 201216
Table 146: Russia exchange rate, 201216
Table 147: Scandinavia pharmaceuticals market value: $ billion, 201216
Table 148: Scandinavia pharmaceuticals market geography segmentation: $ billion, 2016
Table 149: Scandinavia pharmaceuticals market share: % share, by value, 2016
Table 150: Scandinavia pharmaceuticals market value forecast: $ billion, 201621
Table 151: Singapore pharmaceuticals market value: $ billion, 201216
Table 152: Singapore pharmaceuticals market geography segmentation: $ billion, 2016
Table 153: Singapore pharmaceuticals market share: % share, by value, 2016
Table 154: Singapore pharmaceuticals market value forecast: $ billion, 201621
Table 155: Singapore size of population (million), 201216
Table 156: Singapore gdp (constant 2005 prices, $ billion), 201216
Table 157: Singapore gdp (current prices, $ billion), 201216
Table 158: Singapore inflation, 201216
Table 159: Singapore consumer price index (absolute), 201216
Table 160: Singapore exchange rate, 201216
Table 161: South Africa pharmaceuticals market value: $ billion, 201216
Table 162: South Africa pharmaceuticals market geography segmentation: $ billion, 2016
Table 163: South Africa pharmaceuticals market share: % share, by value, 2016
Table 164: South Africa pharmaceuticals market value forecast: $ billion, 201621
Table 165: South Africa size of population (million), 201216
Table 166: South Africa gdp (constant 2005 prices, $ billion), 201216
Table 167: South Africa gdp (current prices, $ billion), 201216
Table 168: South Africa inflation, 201216
Table 169: South Africa consumer price index (absolute), 201216
Table 170: South Africa exchange rate, 201216
Table 171: South Korea pharmaceuticals market value: $ billion, 201216
Table 172: South Korea pharmaceuticals market geography segmentation: $ billion, 2016
Table 173: South Korea pharmaceuticals market share: % share, by value, 2016
Table 174: South Korea pharmaceuticals market value forecast: $ billion, 201621
Table 175: South Korea size of population (million), 201216
Table 176: South Korea gdp (constant 2005 prices, $ billion), 201216
Table 177: South Korea gdp (current prices, $ billion), 201216
Table 178: South Korea inflation, 201216
Table 179: South Korea consumer price index (absolute), 201216
Table 180: South Korea exchange rate, 201216
Table 181: Spain pharmaceuticals market value: $ billion, 201216
Table 182: Spain pharmaceuticals market geography segmentation: $ billion, 2016
Table 183: Spain pharmaceuticals market share: % share, by value, 2016
Table 184: Spain pharmaceuticals market value forecast: $ billion, 201621
Table 185: Spain size of population (million), 201216
Table 186: Spain gdp (constant 2005 prices, $ billion), 201216
Table 187: Spain gdp (current prices, $ billion), 201216
Table 188: Spain inflation, 201216
Table 189: Spain consumer price index (absolute), 201216
Table 190: Spain exchange rate, 201216
Table 191: Turkey pharmaceuticals market value: $ billion, 201216
Table 192: Turkey pharmaceuticals market geography segmentation: $ billion, 2016
Table 193: Turkey pharmaceuticals market share: % share, by value, 2016
Table 194: Turkey pharmaceuticals market value forecast: $ billion, 201621
Table 195: Turkey size of population (million), 201216
Table 196: Turkey gdp (constant 2005 prices, $ billion), 201216
Table 197: Turkey gdp (current prices, $ billion), 201216
Table 198: Turkey inflation, 201216
Table 199: Turkey consumer price index (absolute), 201216
Table 200: Turkey exchange rate, 201216
Table 201: United Kingdom pharmaceuticals market value: $ billion, 201216
Table 202: United Kingdom pharmaceuticals market geography segmentation: $ billion, 2016
Table 203: United Kingdom pharmaceuticals market share: % share, by value, 2016
Table 204: United Kingdom pharmaceuticals market value forecast: $ billion, 201621
Table 205: United Kingdom size of population (million), 201216
Table 206: United Kingdom gdp (constant 2005 prices, $ billion), 201216
Table 207: United Kingdom gdp (current prices, $ billion), 201216
Table 208: United Kingdom inflation, 201216
Table 209: United Kingdom consumer price index (absolute), 201216
Table 210: United Kingdom exchange rate, 201216
Table 211: United States pharmaceuticals market value: $ billion, 201216
Table 212: United States pharmaceuticals market geography segmentation: $ billion, 2016
Table 213: United States pharmaceuticals market share: % share, by value, 2016
Table 214: United States pharmaceuticals market value forecast: $ billion, 201621
Table 215: United States size of population (million), 201216
Table 216: United States gdp (constant 2005 prices, $ billion), 201216
Table 217: United States gdp (current prices, $ billion), 201216
Table 218: United States inflation, 201216
Table 219: United States consumer price index (absolute), 201216
Table 220: United States exchange rate, 201215
Table 221: Bayer AG: key facts
Table 222: Bayer AG: key financials ($)
Table 223: Bayer AG: key financials ()
Table 224: Bayer AG: key financial ratios
Table 225: Johnson & Johnson: key facts
Table 226: Johnson & Johnson: key financials ($)
Table 227: Johnson & Johnson: key financial ratios
Table 228: Novartis AG: key facts
Table 229: Novartis AG: key financials ($)
Table 230: Novartis AG: key financial ratios
Table 231: Pfizer Inc.: key facts
Table 232: Pfizer Inc.: key financials ($)
Table 233: Pfizer Inc.: key financial ratios
Table 234: Takeda Pharmaceutical Company Limited: key facts
Table 235: Takeda Pharmaceutical Company Limited: key financials ($)
Table 236: Takeda Pharmaceutical Company Limited: key financials ()
Table 237: Takeda Pharmaceutical Company Limited: key financial ratios
Table 238: Sanofi SA: key facts
Table 239: Sanofi SA: key financials ($)
Table 240: Sanofi SA: key financials ()
Table 241: Sanofi SA: key financial ratios
Table 242: AstraZeneca PLC: key facts
Table 243: AstraZeneca PLC: key financials ($)
Table 244: AstraZeneca PLC: key financial ratios
Table 245: Laboratoires Pierre Fabre SA: key facts
Table 246: Les Laboratoires Servier: key facts
Table 247: Boehringer Ingelheim GmbH: key facts
Table 248: Boehringer Ingelheim GmbH: key financials ($)
Table 249: Boehringer Ingelheim GmbH: key financials ()
Table 250: Boehringer Ingelheim GmbH: key financial ratios
Table 251: GlaxoSmithKline Plc: key facts
Table 252: GlaxoSmithKline Plc: key financials ($)
Table 253: GlaxoSmithKline Plc: key financials ()
Table 254: GlaxoSmithKline Plc: key financial ratios
Table 255: Ach Laboratrios Farmacuticos S.A.: key facts
Table 256: EMS SA: key facts
Table 257: Apotex, Inc.: key facts
Table 258: Merck & Co., Inc.: key facts
Table 259: Merck & Co., Inc.: key financials ($)
Table 260: Merck & Co., Inc.: key financial ratios
Table 261: Guangzhou Pharmaceutical Holdings Limited: key facts
Table 262: Shanghai Pharmaceuticals Holding Co Ltd: key facts
Table 263: Shanghai Pharmaceuticals Holding Co Ltd: key financials ($)
Table 264: Shanghai Pharmaceuticals Holding Co Ltd: key financials (CNY)
Table 265: Shanghai Pharmaceuticals Holding Co Ltd: key financial ratios
Table 266: Yangtze River Pharmaceutical Group: key facts
Table 267: Yunnan Baiyao Group Co., Ltd.: key facts
Table 268: Yunnan Baiyao Group Co., Ltd.: key financials ($)
Table 269: Yunnan Baiyao Group Co., Ltd.: key financials (CNY)
Table 270: Yunnan Baiyao Group Co., Ltd.: key financial ratios
Table 271: Aurobindo Pharma Limited: key facts
Table 272: Aurobindo Pharma Limited: key financials ($)
Table 273: Aurobindo Pharma Limited: key financials (Rs.)
Table 274: Aurobindo Pharma Limited: key financial ratios
Table 275: Lupin Limited: key facts
Table 276: Lupin Limited: key financials ($)
Table 277: Lupin Limited: key financials (Rs.)
Table 278: Lupin Limited: key financial ratios
Table 279: Dr. Reddy's Laboratories Limited: key facts
Table 280: Dr. Reddy's Laboratories Limited: key financials ($)
Table 281: Dr. Reddy's Laboratories Limited: key financials (Rs.)
Table 282: Dr. Reddy's Laboratories Limited: key financial ratios
Table 283: Sun Pharmaceutical Industries Ltd.: key facts
Table 284: Sun Pharmaceutical Industries Ltd.: key financials ($)
Table 285: Sun Pharmaceutical Industries Ltd.: key financials (Rs.)
Table 286: Sun Pharmaceutical Industries Ltd.: key financial ratios
Table 287: PT Kalbe Farma Tbk: key facts
Table 288: PT Kalbe Farma Tbk: key financials ($)
Table 289: PT Kalbe Farma Tbk: key financials (IDR)
Table 290: PT Kalbe Farma Tbk: key financial ratios
Table 291: Chiesi Farmaceutici S.p.A.: key facts
Table 292: The Menarini Group: key facts
Table 293: Recordati S.p.A.: key facts
Table 294: Daiichi Sankyo Co., Ltd.: key facts
Table 295: Daiichi Sankyo Co., Ltd.: key financials ($)
Table 296: Daiichi Sankyo Co., Ltd.: key financials ()
Table 297: Daiichi Sankyo Co., Ltd.: key financial ratios
Table 298: Mitsubishi Tanabe Pharma Corporation: key facts
Table 299: Mitsubishi Tanabe Pharma Corporation: key financials ($)
Table 300: Mitsubishi Tanabe Pharma Corporation: key financials ()
Table 301: Mitsubishi Tanabe Pharma Corporation: key financial ratios
Table 302: F. Hoffmann-La Roche Ltd: key facts
Table 303: F. Hoffmann-La Roche Ltd: key financials ($)
Table 304: F. Hoffmann-La Roche Ltd: key financials (CHF)
Table 305: F. Hoffmann-La Roche Ltd: key financial ratios
Table 306: Astellas Pharma Inc.: key facts
Table 307: Astellas Pharma Inc.: key financials ($)
Table 308: Astellas Pharma Inc.: key financials ()
Table 309: Astellas Pharma Inc.: key financial ratios
Table 310: Adcock Ingram Holdings Limited: key facts
Table 311: Adcock Ingram Holdings Limited: key financials ($)
Table 312: Adcock Ingram Holdings Limited: key financials (ZAR)
Table 313: Adcock Ingram Holdings Limited: key financial ratios
Table 314: Aspen Pharmacare Holdings Ltd: key facts
Table 315: Aspen Pharmacare Holdings Ltd: key financials ($)
Table 316: Aspen Pharmacare Holdings Ltd: key financials (ZAR)
Table 317: Aspen Pharmacare Holdings Ltd: key financial ratios
Table 318: CKD Bio Corporation: key facts
Table 319: Daewoong Pharmaceutical Co., Ltd.: key facts
Table 320: Daewoong Pharmaceutical Co., Ltd.: key financials ($)
Table 321: Daewoong Pharmaceutical Co., Ltd.: key financials (KRW)
Table 322: Daewoong Pharmaceutical Co., Ltd.: key financial ratios
Table 323: Hanmi Science Co., Ltd.: key facts
Table 324: Hanmi Science Co., Ltd.: key financials ($)
Table 325: Hanmi Science Co., Ltd.: key financials (KRW)
Table 326: Hanmi Science Co., Ltd.: key financial ratios
Table 327: Almirall S.A.: key facts
Table 328: Almirall S.A.: key financials ($)
Table 329: Almirall S.A.: key financials ()
Table 330: Almirall S.A.: key financial ratios
Table 331: Abdi brahim: key facts

List of Figures
Figure 1: Global pharmaceuticals market value: $ billion, 201216
Figure 2: Global pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 3: Global pharmaceuticals market share: % share, by value, 2016
Figure 4: Global pharmaceuticals market value forecast: $ billion, 201621
Figure 5: Forces driving competition in the global pharmaceuticals market, 2016
Figure 6: Drivers of buyer power in the global pharmaceuticals market, 2016
Figure 7: Drivers of supplier power in the global pharmaceuticals market, 2016
Figure 8: Factors influencing the likelihood of new entrants in the global pharmaceuticals market, 2016
Figure 9: Factors influencing the threat of substitutes in the global pharmaceuticals market, 2016
Figure 10: Drivers of degree of rivalry in the global pharmaceuticals market, 2016
Figure 11: Asia-Pacific pharmaceuticals market value: $ billion, 201216
Figure 12: AsiaPacific pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 13: Asia-Pacific pharmaceuticals market share: % share, by value, 2016
Figure 14: Asia-Pacific pharmaceuticals market value forecast: $ billion, 201621
Figure 15: Forces driving competition in the pharmaceuticals market in Asia-Pacific, 2016
Figure 16: Drivers of buyer power in the pharmaceuticals market in Asia-Pacific, 2016
Figure 17: Drivers of supplier power in the pharmaceuticals market in Asia-Pacific, 2016
Figure 18: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Asia-Pacific, 2016
Figure 19: Factors influencing the threat of substitutes in the pharmaceuticals market in Asia-Pacific, 2016
Figure 20: Drivers of degree of rivalry in the pharmaceuticals market in Asia-Pacific, 2016
Figure 21: Europe pharmaceuticals market value: $ billion, 201216
Figure 22: Europe pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 23: Europe pharmaceuticals market share: % share, by value, 2016
Figure 24: Europe pharmaceuticals market value forecast: $ billion, 201621
Figure 25: Forces driving competition in the pharmaceuticals market in Europe, 2016
Figure 26: Drivers of buyer power in the pharmaceuticals market in Europe, 2016
Figure 27: Drivers of supplier power in the pharmaceuticals market in Europe, 2016
Figure 28: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Europe, 2016
Figure 29: Factors influencing the threat of substitutes in the pharmaceuticals market in Europe, 2016
Figure 30: Drivers of degree of rivalry in the pharmaceuticals market in Europe, 2016
Figure 31: France pharmaceuticals market value: $ billion, 201216
Figure 32: France pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 33: France pharmaceuticals market share: % share, by value, 2016
Figure 34: France pharmaceuticals market value forecast: $ billion, 201621
Figure 35: Forces driving competition in the pharmaceuticals market in France, 2016
Figure 36: Drivers of buyer power in the pharmaceuticals market in France, 2016
Figure 37: Drivers of supplier power in the pharmaceuticals market in France, 2016
Figure 38: Factors influencing the likelihood of new entrants in the pharmaceuticals market in France, 2016
Figure 39: Factors influencing the threat of substitutes in the pharmaceuticals market in France, 2016
Figure 40: Drivers of degree of rivalry in the pharmaceuticals market in France, 2016
Figure 41: Germany pharmaceuticals market value: $ billion, 201216
Figure 42: Germany pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 43: Germany pharmaceuticals market share: % share, by value, 2016
Figure 44: Germany pharmaceuticals market value forecast: $ billion, 201621
Figure 45: Forces driving competition in the pharmaceuticals market in Germany, 2016
Figure 46: Drivers of buyer power in the pharmaceuticals market in Germany, 2016
Figure 47: Drivers of supplier power in the pharmaceuticals market in Germany, 2016
Figure 48: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Germany, 2016
Figure 49: Factors influencing the threat of substitutes in the pharmaceuticals market in Germany, 2016
Figure 50: Drivers of degree of rivalry in the pharmaceuticals market in Germany, 2016
Figure 51: Australia pharmaceuticals market value: $ billion, 201216
Figure 52: Australia pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 53: Australia pharmaceuticals market share: % share, by value, 2016
Figure 54: Australia pharmaceuticals market value forecast: $ billion, 201621
Figure 55: Forces driving competition in the pharmaceuticals market in Australia, 2016
Figure 56: Drivers of buyer power in the pharmaceuticals market in Australia, 2016
Figure 57: Drivers of supplier power in the pharmaceuticals market in Australia, 2016
Figure 58: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Australia, 2016
Figure 59: Factors influencing the threat of substitutes in the pharmaceuticals market in Australia, 2016
Figure 60: Drivers of degree of rivalry in the pharmaceuticals market in Australia, 2016
Figure 61: Brazil pharmaceuticals market value: $ billion, 201216
Figure 62: Brazil pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 63: Brazil pharmaceuticals market share: % share, by value, 2016
Figure 64: Brazil pharmaceuticals market value forecast: $ billion, 201621
Figure 65: Forces driving competition in the pharmaceuticals market in Brazil, 2016
Figure 66: Drivers of buyer power in the pharmaceuticals market in Brazil, 2016
Figure 67: Drivers of supplier power in the pharmaceuticals market in Brazil, 2016
Figure 68: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Brazil, 2016
Figure 69: Factors influencing the threat of substitutes in the pharmaceuticals market in Brazil, 2016
Figure 70: Drivers of degree of rivalry in the pharmaceuticals market in Brazil, 2016
Figure 71: Canada pharmaceuticals market value: $ billion, 201216
Figure 72: Canada pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 73: Canada pharmaceuticals market share: % share, by value, 2016
Figure 74: Canada pharmaceuticals market value forecast: $ billion, 201621
Figure 75: Forces driving competition in the pharmaceuticals market in Canada, 2016
Figure 76: Drivers of buyer power in the pharmaceuticals market in Canada, 2016
Figure 77: Drivers of supplier power in the pharmaceuticals market in Canada, 2016
Figure 78: Factors influencing the likelihood of new entrants in the pharmaceuticals market in Canada, 2016
Figure 79: Factors influencing the threat of substitutes in the pharmaceuticals market in Canada, 2016
Figure 80: Drivers of degree of rivalry in the pharmaceuticals market in Canada, 2016
Figure 81: China pharmaceuticals market value: $ billion, 201216
Figure 82: China pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 83: China pharmaceuticals market share: % share, by value, 2016
Figure 84: China pharmaceuticals market value forecast: $ billion, 201621
Figure 85: Forces driving competition in the pharmaceuticals market in China, 2016
Figure 86: Drivers of buyer power in the pharmaceuticals market in China, 2016
Figure 87: Drivers of supplier power in the pharmaceuticals market in China, 2016
Figure 88: Factors influencing the likelihood of new entrants in the pharmaceuticals market in China, 2016
Figure 89: Factors influencing the threat of substitutes in the pharmaceuticals market in China, 2016
Figure 90: Drivers of degree of rivalry in the pharmaceuticals market in China, 2016
Figure 91: India pharmaceuticals market value: $ billion, 201216
Figure 92: India pharmaceuticals market geography segmentation: % share, by value, 2016
Figure 93: India pharmaceuticals market share: % share, by value, 2016
Figure 94: India pharmaceuticals market value forecast: $ billion, 201621
Figure 95: Forces driving competition in the pharmaceuticals market in India, 2016
Figure 96: Drivers of buyer power in the pharmaceuticals market in India, 2016
Figure 97: Drivers of supplier power in the pharmaceuticals market in India, 2016
Figure 98: Factors influencing the like

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *